ICU Management: ARDS + Acute Pancreatitis

PART 1 — ARDS

Berlin Definition & Classification

Treatment — Escalating by Severity

1. Lung-Protective Ventilation (ALL ARDS — cornerstone)

• Tidal volume: 6 mL/kg PBW (start 6–8, reduce by 1 mL/kg q2h to reach 6)
  • PBW men: 50 + 2.3 kg per inch over 5 ft
  • PBW women: 45.5 + 2.3 kg per inch over 5 ft
• Plateau pressure: <30 cmH₂O (can reduce TV to 4 mL/kg if needed)
• Oxygenation targets: PaO₂ 55–80 mmHg or SpO₂ 88–95%
• Evidence: ARMA trial — 6 mL/kg vs 12 mL/kg → significant mortality reduction

2. PEEP Titration

• Titrate PEEP using FiO₂/PEEP tables (higher PEEP for moderate–severe ARDS)
• Example high-PEEP table:

• ARDS subphenotypes matter: hyperinflammatory (subphenotype 2) benefits from high PEEP; hypoinflammatory (subphenotype 1) does better with low PEEP

3. Driving Pressure

• ΔP = Plateau pressure − PEEP (reflects tidal volume normalized to lung size)
• Even with "safe" TV and plateau pressures, elevated driving pressure is associated with increased mortality
• Target driving pressure minimization as an independent ventilator goal

4. Permissive Hypercapnia

• Accept elevated PaCO₂ to allow lower tidal volumes and pressures
• Respiratory acidosis managed with NaHCO₃ or THAM
• Caution in TBI — worsens intracranial pressure

5. Prone Positioning (Moderate–Severe ARDS, P:F <150)

• Mechanism: V/Q matching + recruits dependent lung zones
• PROSEVA trial: ≥16 hours/day pronation → 90-day mortality 23.6% vs 41% in supine
• Initiate within 36 hours of onset
• Risks: unplanned extubation, pressure sores, line dislodgement — careful planning essential

6. Conservative Fluid Management

• Target lowest CVP consistent with adequate perfusion
• Consider diuretics when hypoxemia + CVP >4 cmH₂O
• FACTT trial reanalysis: hyperinflammatory subphenotype benefits from conservative strategy; hypoinflammatory from liberal

7. Neuromuscular Blockade (Moderate–Severe, P:F ≤150, <36 h)

• Reduces ventilator dyssynchrony, consumptive O₂ use, excessive tidal volumes
• ACURASYS trial: improved 90-day survival; ROSE trial showed no mortality benefit with light sedation comparison
• Current status: salvage/adjunct for severe ARDS, not routine

8. Corticosteroids

• Early ARDS (within 14 days): methylprednisolone or dexamethasone shown to increase ventilator-free days and reduce mortality
  • Dexamethasone protocol (Spanish RCT, 277 patients): 20 mg/day × 5 days → 10 mg/day × 5 days IV → 12.3 vs 7.5 ventilator-free days; 60-day mortality 21% vs 36%
• Late ARDS (>14 days): steroids associated with increased 60- and 180-day mortality — avoid
• SCCM/ESICM 2017 guidelines support low-dose methylprednisolone with taper over 28 days in early ARDS

9. Salvage Strategies (Refractory Severe ARDS)

10. NIV/HHFNC

• Applicable to mild ARDS and non-intubated patients only
• High-flow nasal cannula (HHFNC) reduces work of breathing, maintains PEEP effect
• NIV appropriate for selected mild cases; risk of delayed intubation if failing

PART 2 — Acute Pancreatitis (AP) ICU Management

Indications for ICU Admission

• Persistent organ failure >48 hours (defines severe AP)
• Hemodynamic instability requiring vasopressors
• SIRS severe enough to require mechanical ventilation
• Respiratory failure (AP-related ARDS occurs in ~20% of severe AP)

Core ICU Principles

1. Fluid Resuscitation

• Aggressive early IV fluids are a mainstay — correct hypovolemia from third-spacing
• Lactated Ringer's preferred over normal saline (reduced inflammatory markers in trials)
• Monitor for abdominal compartment syndrome — excessive fluids worsen outcomes
• Goal-directed resuscitation: target urine output, HR, MAP, lactate clearance

2. Nutrition — Paradigm Shift (Critical)

NPO is obsolete in severe AP — early enteral nutrition is now standard of care.

• ICU patients with severe AP: place NG/NJ tube and initiate EN within 24–36 hours of admission
• Two meta-analyses: EN vs PN in severe AP → 2-fold reduction in infectious complications, 2.5-fold reduction in mortality
• AGA technical review (12 RCTs): EN reduced infected peripancreatic necrosis (OR 0.28), single organ failure (OR 0.25), and MOF (OR 0.41) vs PN
• Gastric vs jejunal feeding: 3 RCTs showed no significant difference in tolerance or clinical outcomes
• Caution: do not initiate EN in hemodynamically unstable patients requiring high-dose vasopressors — risk of non-occlusive mesenteric ischemia
• If patient is managing on ward with minimal SIRS: offer oral diet as tolerated; start EN only if failing to advance diet after 4 days

3. Analgesia

• AP causes severe pain — adequate analgesia is essential and does not worsen outcomes
• IV opioids (morphine, fentanyl, hydromorphone) are appropriate
• Epidural analgesia may be considered in severe cases
• Avoid NSAIDs (renal impairment risk in a volume-depleted patient)

4. Management of Infected Pancreatic Necrosis

• Sterile necrosis: no prophylactic antibiotics (evidence does not support them)
• Infected necrosis (fever + CT evidence of necrosis with gas, or positive FNA): antibiotics — carbapenems (imipenem) or fluoroquinolones + metronidazole (good pancreatic penetration)
• Intervention: step-up approach — percutaneous/endoscopic drainage before open necrosectomy
• Timing: delay necrosectomy ≥4 weeks to allow walling-off (better outcomes)

5. Glycemic Control

• Pancreatitis disrupts endocrine function → hyperglycemia common
• Target glucose 140–180 mg/dL in ICU (tight control <110 increases hypoglycemia risk)
• Insulin infusion as needed

6. Organ Support

7. Biliary AP

• Urgent ERCP (within 24–72 h) only if concurrent cholangitis or biliary obstruction
• No benefit of ERCP in predicted severe AP without cholangitis
• Cholecystectomy before discharge for biliary AP (or interval in severe cases)

8. Monitoring

• CT abdomen with contrast: not required on admission; indicated at 48–72 h if clinical deterioration or diagnostic uncertainty (CT Severity Index / Balthazar score)
• Serial labs: CRP (>150 mg/L at 48 h = severe disease), CBC, LFTs, creatinine, calcium, glucose, lactate

AP-Related ARDS: The Overlap

• Apply all ARDS management principles above
• Nutritional strategy: continue EN (jejunal) even with ARDS if hemodynamically stable
• Abdominal compartment syndrome can worsen respiratory compliance → monitor intra-abdominal pressure
• The hyperinflammatory ARDS subphenotype is most likely in sepsis-driven AP-ARDS